Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "A Ph1 Trial of Dose-Adjusted EPOCH + Inotuzumab Ozogamicin in Adults With R/R B-ALL"

131 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login